Dermochelys coriacea isolate rDerCor1 chromosome 22, rDerCor1.pri.v4, whole genome shotgun sequence.
Dermochelys coriacea (leatherback sea turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Dermochelyidae; Dermochelys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM019956.3.\nAssembly name: rDerCor1.pri.v4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the G10K on 2021/08/25. The\noriginal whole-genome shotgun project has the accession\nWSPL00000000.4.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: G10K\nAssembly Date :: 24-MAY-2021\nAssembly Method :: FALCON DNANexus v. 1.9.0; FALCON-Unzip\n DNANexus v. 1.0.6; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.2.1; Salsa HiC v. 2.2.2; Arrow\n smrtanalysis Pacbio polishing & gap\n filling v. 6.0.0.47841; longranger align\n v. 2.2.2; freebayes Illumina polishing v.\n 1.3.1; gEVAL manual curation v.\n 2021-05-24; VGP assembly pipeline\n individual v. 1.6\nAssembly Name :: rDerCor1.pri.v4\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 63.68x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Dermochelys coriacea Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122457200, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122457200, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122457200, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
fasciculation and elongation protein zeta 1, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
fasciculation and elongation protein zeta 1, transcript variant X1
fasciculation and elongation protein zeta 1, transcript variant X3
fasciculation and elongation protein zeta 1, transcript variant X2
fasciculation and elongation protein zeta-1 isoform X1
fasciculation and elongation protein zeta-1 isoform X2
fasciculation and elongation protein zeta-1 isoform X3
PBX/knotted 1 homeobox 2, transcript variant X7
PBX/knotted 1 homeobox 2, transcript variant X5
PBX/knotted 1 homeobox 2, transcript variant X2
PBX/knotted 1 homeobox 2, transcript variant X4
PBX/knotted 1 homeobox 2, transcript variant X6
PBX/knotted 1 homeobox 2, transcript variant X3
PBX/knotted 1 homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 218, transcript variant X1
transmembrane protein 218, transcript variant X2
transmembrane protein 218, transcript variant X4
transmembrane protein 218, transcript variant X5
transmembrane protein 218, transcript variant X3
solute carrier family 37 member 2, transcript variant X2
solute carrier family 37 member 2, transcript variant X3
solute carrier family 37 member 2, transcript variant X4
glucose-6-phosphate exchanger SLC37A2 isoform X3
glucose-6-phosphate exchanger SLC37A2 isoform X2
glucose-6-phosphate exchanger SLC37A2 isoform X4
solute carrier family 37 member 2, transcript variant X1
glucose-6-phosphate exchanger SLC37A2 isoform X1
hepatic and glial cell adhesion molecule, transcript variant X1
hepatic and glial cell adhesion molecule, transcript variant X3
hepatic and glial cell adhesion molecule, transcript variant X2
hepatic and glial cell adhesion molecule, transcript variant X4
hepatocyte cell adhesion molecule isoform X1
hepatic and glial cell adhesion molecule, transcript variant X5
hepatocyte cell adhesion molecule isoform X2
roundabout guidance receptor 4, transcript variant X1
roundabout guidance receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
roundabout guidance receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
roundabout guidance receptor 3, transcript variant X3
roundabout guidance receptor 3, transcript variant X2
roundabout guidance receptor 3, transcript variant X1
roundabout guidance receptor 3, transcript variant X7
roundabout guidance receptor 3, transcript variant X6
roundabout guidance receptor 3, transcript variant X5
roundabout guidance receptor 3, transcript variant X4
uncharacterized LOC122457226, transcript variant X2
uncharacterized LOC122457226, transcript variant X1
Myb/SANT DNA binding domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X1
Myb/SANT DNA binding domain containing 2, transcript variant X2
Myb/SANT DNA binding domain containing 2, transcript variant X3
myb/SANT-like DNA-binding domain-containing protein 2 isoform X4
myb/SANT-like DNA-binding domain-containing protein 2 isoform X1
myb/SANT-like DNA-binding domain-containing protein 2 isoform X2
myb/SANT-like DNA-binding domain-containing protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: endothelial cell-selective adhesion molecule
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
V-set and immunoglobulin domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 2
sialic acid acetylesterase, transcript variant X1
sialic acid acetylesterase, transcript variant X3
sialic acid acetylesterase, transcript variant X4
sialic acid acetylesterase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitochondrial RNA pseudouridine synthase RPUSD4
V-set and immunoglobulin domain containing 10 like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 10-like 2
cell adhesion associated, oncogene regulated, transcript variant X1
cell adhesion associated, oncogene regulated, transcript variant X2
cell adhesion associated, oncogene regulated, transcript variant X3
cell adhesion associated, oncogene regulated, transcript variant X4
cell adhesion molecule-related/down-regulated by oncogenes isoform X1
cell adhesion molecule-related/down-regulated by oncogenes isoform X2
wiskott-Aldrich syndrome protein homolog 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
prostate and testis expressed protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase Chk1
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X1
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X2
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
EI24 autophagy associated transmembrane protein, transcript variant X3
EI24 autophagy associated transmembrane protein, transcript variant X2
EI24 autophagy associated transmembrane protein, transcript variant X1
EI24 autophagy associated transmembrane protein, transcript variant X4
etoposide-induced protein 2.4 homolog isoform X1
etoposide-induced protein 2.4 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
gastrokine-2-like, transcript variant X3
gastrokine-2-like, transcript variant X1
gastrokine-2-like, transcript variant X2
pulmonary surfactant-associated protein C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 118 member B, transcript variant X7
family with sequence similarity 118 member B, transcript variant X1
family with sequence similarity 118 member B, transcript variant X5
family with sequence similarity 118 member B, transcript variant X2
family with sequence similarity 118 member B, transcript variant X6
family with sequence similarity 118 member B, transcript variant X3
family with sequence similarity 118 member B, transcript variant X4
signal recognition particle receptor subunit alpha
FAD dependent oxidoreductase domain containing 1
FAD-dependent oxidoreductase domain-containing protein 1
cryptochrome-1-like, transcript variant X3
cryptochrome-1-like, transcript variant X4
cryptochrome-1-like, transcript variant X2
cryptochrome-1-like, transcript variant X1
TIR domain containing adaptor protein, transcript variant X1
toll/interleukin-1 receptor domain-containing adapter protein isoform X1
TIR domain containing adaptor protein, transcript variant X4
TIR domain containing adaptor protein, transcript variant X8
TIR domain containing adaptor protein, transcript variant X7
TIR domain containing adaptor protein, transcript variant X3
TIR domain containing adaptor protein, transcript variant X6
TIR domain containing adaptor protein, transcript variant X2
TIR domain containing adaptor protein, transcript variant X5
toll/interleukin-1 receptor domain-containing adapter protein isoform X2
toll/interleukin-1 receptor domain-containing adapter protein isoform X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X6
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X12
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X5
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X13
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X6
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X7
kirre like nephrin family adhesion molecule 3, transcript variant X2
kirre like nephrin family adhesion molecule 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ETS proto-oncogene 1, transcription factor, transcript variant X1
ETS proto-oncogene 1, transcription factor, transcript variant X2
uncharacterized LOC122457216, transcript variant X2
uncharacterized LOC122457216, transcript variant X1
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X7
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X6
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X5
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X4
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X8
Friend leukemia integration 1 transcription factor isoform X3
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X9
Friend leukemia integration 1 transcription factor isoform X4
potassium inwardly rectifying channel subfamily J member 5
potassium inwardly rectifying channel subfamily J member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium inwardly rectifying channel subfamily J member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium inwardly rectifying channel subfamily J member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP-sensitive inward rectifier potassium channel 1
G protein-activated inward rectifier potassium channel 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho GTPase-activating protein 32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 45B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
amyloid beta precursor like protein 2, transcript variant X7
amyloid beta precursor like protein 2, transcript variant X9
amyloid beta precursor like protein 2, transcript variant X3
amyloid beta precursor like protein 2, transcript variant X6
amyloid beta precursor like protein 2, transcript variant X5
amyloid beta precursor like protein 2, transcript variant X4
amyloid beta precursor like protein 2, transcript variant X2
amyloid beta precursor like protein 2, transcript variant X1
amyloid beta precursor like protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
PR/SET domain 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
PR/SET domain 10, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
PR/SET domain 10, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
PR domain zinc finger protein 10 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
PR domain zinc finger protein 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PR domain zinc finger protein 10 isoform X1
PR domain zinc finger protein 10 isoform X5
PR domain zinc finger protein 10 isoform X3
PR domain zinc finger protein 10 isoform X7
PR domain zinc finger protein 10 isoform X6
nuclear factor related to kappaB binding protein, transcript variant X4
nuclear factor related to kappaB binding protein, transcript variant X7
nuclear factor related to kappaB binding protein, transcript variant X6
nuclear factor related to kappaB binding protein, transcript variant X1
nuclear factor related to kappaB binding protein, transcript variant X5
nuclear factor related to kappaB binding protein, transcript variant X3
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappa-B-binding protein isoform X1
nuclear factor related to kappa-B-binding protein isoform X3
nuclear factor related to kappa-B-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
ST14 transmembrane serine protease matriptase, transcript variant X5
ST14 transmembrane serine protease matriptase, transcript variant X2
ST14 transmembrane serine protease matriptase, transcript variant X1
ST14 transmembrane serine protease matriptase, transcript variant X3
suppressor of tumorigenicity 14 protein isoform X1
suppressor of tumorigenicity 14 protein isoform X2
suppressor of tumorigenicity 14 protein isoform X3
ST14 transmembrane serine protease matriptase, transcript variant X6
ST14 transmembrane serine protease matriptase, transcript variant X4
suppressor of tumorigenicity 14 protein isoform X4
uncharacterized LOC119846807, transcript variant X3
uncharacterized LOC119846807, transcript variant X2
uncharacterized LOC119846807, transcript variant X1
uncharacterized LOC119846807, transcript variant X4
zinc finger and BTB domain containing 44, transcript variant X5
zinc finger and BTB domain containing 44, transcript variant X3
zinc finger and BTB domain-containing protein 44 isoform X2
zinc finger and BTB domain containing 44, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X9
zinc finger and BTB domain containing 44, transcript variant X1
zinc finger and BTB domain containing 44, transcript variant X2
zinc finger and BTB domain-containing protein 44 isoform X1
zinc finger and BTB domain-containing protein 44 isoform X3
ADAM metallopeptidase with thrombospondin type 1 motif 8
A disintegrin and metalloproteinase with thrombospondin motifs 8
ADAM metallopeptidase with thrombospondin type 1 motif 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC119846721, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
opioid-binding protein/cell adhesion molecule homolog, transcript variant X4
opioid-binding protein/cell adhesion molecule homolog, transcript variant X2
opioid-binding protein/cell adhesion molecule homolog, transcript variant X1
opioid-binding protein/cell adhesion molecule homolog, transcript variant X3
uncharacterized LOC119846721, transcript variant X1
opioid-binding protein/cell adhesion molecule homolog isoform X4
opioid-binding protein/cell adhesion molecule homolog isoform X2
opioid-binding protein/cell adhesion molecule isoform X3
opioid-binding protein/cell adhesion molecule isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: spermatogenesis-associated protein 19, mitochondrial
immunoglobulin superfamily member 9B, transcript variant X2
immunoglobulin superfamily member 9B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
junctional adhesion molecule 3, transcript variant X2
junctional adhesion molecule C isoform X2
junctional adhesion molecule 3, transcript variant X1
junctional adhesion molecule C isoform X1
non-SMC condensin II complex subunit D3, transcript variant X1
non-SMC condensin II complex subunit D3, transcript variant X2
condensin-2 complex subunit D3 isoform X2
condensin-2 complex subunit D3 isoform X1
vacuolar protein sorting-associated protein 26B
thymocyte nuclear protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X2
isobutyryl-CoA dehydrogenase, mitochondrial
galactosidase beta 1 like 2, transcript variant X2
galactosidase beta 1 like 2, transcript variant X1
galactosidase beta 1 like 2, transcript variant X3
beta-galactosidase-1-like protein 2 isoform X1
beta-galactosidase-1-like protein 2 isoform X2
galactosidase beta 1 like 2, transcript variant X4
beta-galactosidase-1-like protein 2 isoform X3
beta-1,3-glucuronyltransferase 1, transcript variant X5
beta-1,3-glucuronyltransferase 1, transcript variant X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X2
beta-1,3-glucuronyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X7
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X6
uncharacterized LOC119846674, transcript variant X1
uncharacterized LOC119846674, transcript variant X2
uncharacterized LOC119846674, transcript variant X3
adventurous-gliding motility protein Z-like
fibrous sheath CABYR-binding protein-like, transcript variant X3
fibrous sheath CABYR-binding protein-like, transcript variant X4
fibrous sheath CABYR-binding protein-like, transcript variant X5
fibrous sheath CABYR-binding protein-like, transcript variant X1
fibrous sheath CABYR-binding protein-like, transcript variant X2
fibrous sheath CABYR-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neurogenic locus notch homolog protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
ATPase H+/K+ transporting non-gastric alpha2 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 150 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium-transporting ATPase alpha chain 2
sodium voltage-gated channel beta subunit 3, transcript variant X3
sodium voltage-gated channel beta subunit 3, transcript variant X2
sodium voltage-gated channel beta subunit 3, transcript variant X1
sodium channel subunit beta-3 isoform X1
sodium channel subunit beta-3 isoform X2
sodium voltage-gated channel beta subunit 3, transcript variant X4
sodium channel subunit beta-3 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
heat shock protein family A (Hsp70) member 8
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00016
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
junctional cadherin complex regulator, transcript variant X2
junctional cadherin complex regulator, transcript variant X1
junctional cadherin complex regulator, transcript variant X5
junctional cadherin complex regulator, transcript variant X3
junctional cadherin complex regulator, transcript variant X4
junctional cadherin complex regulator, transcript variant X6
cytotoxic and regulatory T cell molecule, transcript variant X2
cytotoxic and regulatory T cell molecule, transcript variant X1
cytotoxic and regulatory T-cell molecule isoform X2
cytotoxic and regulatory T-cell molecule isoform X1
ubiquitin associated and SH3 domain containing B, transcript variant X1
ubiquitin associated and SH3 domain containing B, transcript variant X2
ubiquitin associated and SH3 domain containing B, transcript variant X3
ubiquitin-associated and SH3 domain-containing protein B isoform X2
ubiquitin-associated and SH3 domain-containing protein B isoform X1
ubiquitin-associated and SH3 domain-containing protein B isoform X3
uncharacterized LOC119846752, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC119846752, transcript variant X2
uncharacterized LOC119846599, transcript variant X2
uncharacterized LOC119846599, transcript variant X1
sortilin related receptor 1, transcript variant X1
sortilin related receptor 1, transcript variant X3
sortilin related receptor 1, transcript variant X2
uncharacterized LOC122457192, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122457192, transcript variant X1
uncharacterized LOC122457191, transcript variant X2
uncharacterized LOC122457191, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sterol-C5-desaturase, transcript variant X2
sterol-C5-desaturase, transcript variant X3
sterol-C5-desaturase, transcript variant X1
uncharacterized LOC122457230, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122457230, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122457230, transcript variant X3
tubulin-specific chaperone cofactor E-like protein, transcript variant X9
tubulin-specific chaperone cofactor E-like protein, transcript variant X4
tubulin-specific chaperone cofactor E-like protein, transcript variant X3
tubulin-specific chaperone cofactor E-like protein, transcript variant X2
tubulin-specific chaperone cofactor E-like protein, transcript variant X1
tubulin-specific chaperone cofactor E-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin-specific chaperone cofactor E-like protein, transcript variant X7
tubulin-specific chaperone cofactor E-like protein, transcript variant X8
tubulin-specific chaperone cofactor E-like protein, transcript variant X6
tubulin-specific chaperone cofactor E-like protein isoform X2
uncharacterized LOC119846597, transcript variant X1
uncharacterized LOC119846597, transcript variant X2
glutamate ionotropic receptor kainate type subunit 4, transcript variant X1
glutamate ionotropic receptor kainate type subunit 4, transcript variant X4
glutamate ionotropic receptor kainate type subunit 4, transcript variant X3
glutamate ionotropic receptor kainate type subunit 4, transcript variant X2
glutamate receptor ionotropic, kainate 4 isoform X3
glutamate receptor ionotropic, kainate 4 isoform X2
glutamate receptor ionotropic, kainate 4 isoform X1
glutamate ionotropic receptor kainate type subunit 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 12, transcript variant X4
Rho guanine nucleotide exchange factor 12, transcript variant X3
Rho guanine nucleotide exchange factor 12, transcript variant X2
Rho guanine nucleotide exchange factor 12, transcript variant X1
Rho guanine nucleotide exchange factor 12, transcript variant X5
rho guanine nucleotide exchange factor 12 isoform X3
rho guanine nucleotide exchange factor 12 isoform X2
rho guanine nucleotide exchange factor 12 isoform X1
TLC domain-containing protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TLC domain-containing protein 5-like, transcript variant X3
TLC domain-containing protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
POU class 2 homeobox 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
POU class 2 homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 2, transcription factor 3 isoform X1
POU domain, class 2, transcription factor 3 isoform X2
uncharacterized LOC122457211, transcript variant X1
uncharacterized LOC122457211, transcript variant X2
uncharacterized LOC119846608, transcript variant X1
uncharacterized LOC119846608, transcript variant X3
uncharacterized LOC119846608, transcript variant X2
uncharacterized LOC119846609, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC119846609, transcript variant X2
uncharacterized LOC119846609, transcript variant X1
ubiquitin specific peptidase 2, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X1
ubiquitin specific peptidase 2, transcript variant X3
ubiquitin specific peptidase 2, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 2 isoform X1
ubiquitin specific peptidase 2, transcript variant X5
ubiquitin specific peptidase 2, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 2 isoform X3
ubiquitin carboxyl-terminal hydrolase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring finger protein 26, transcript variant X3
ring finger protein 26, transcript variant X1
ring finger protein 26, transcript variant X2
melanoma cell adhesion molecule, transcript variant X1
melanoma cell adhesion molecule, transcript variant X8
melanoma cell adhesion molecule, transcript variant X5
melanoma cell adhesion molecule, transcript variant X2
melanoma cell adhesion molecule, transcript variant X6
melanoma cell adhesion molecule, transcript variant X3
melanoma cell adhesion molecule, transcript variant X4
melanoma cell adhesion molecule, transcript variant X7
melanoma cell adhesion molecule, transcript variant X9
cell surface glycoprotein MUC18 isoform X1
cell surface glycoprotein MUC18 isoform X5
cell surface glycoprotein MUC18 isoform X2
cell surface glycoprotein MUC18 isoform X6
cell surface glycoprotein MUC18 isoform X3
cell surface glycoprotein MUC18 isoform X4
cell surface glycoprotein MUC18 isoform X7
cell surface glycoprotein MUC18 isoform X8
cell surface glycoprotein MUC18 isoform X9
coiled-coil domain containing 153, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 153, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 153
PDZ domain containing 3, transcript variant X3
PDZ domain containing 3, transcript variant X5
PDZ domain containing 3, transcript variant X2
PDZ domain containing 3, transcript variant X1
PDZ domain containing 3, transcript variant X4
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X3
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X5
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X4
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X2
NLR family member X1, transcript variant X1
NLR family member X1, transcript variant X6
NLR family member X1, transcript variant X3
NLR family member X1, transcript variant X2
NLR family member X1, transcript variant X4
NLR family member X1, transcript variant X5
ATP binding cassette subfamily G member 4, transcript variant X1
ATP binding cassette subfamily G member 4, transcript variant X3
ATP binding cassette subfamily G member 4, transcript variant X2
ATP-binding cassette sub-family G member 4 isoform X2
ATP-binding cassette sub-family G member 4 isoform X1
uncharacterized LOC122457218, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122457218, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C11orf53 homolog
POU class 2 homeobox associating factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 79% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
salt inducible kinase 2, transcript variant X1
salt inducible kinase 2, transcript variant X2
salt inducible kinase 2, transcript variant X3
serine/threonine-protein kinase SIK2 isoform X1
serine/threonine-protein kinase SIK2 isoform X2
serine/threonine-protein kinase SIK2 isoform X3
salt inducible kinase 2, transcript variant X4
serine/threonine-protein kinase SIK2 isoform X4
salt inducible kinase 2, transcript variant X6
salt inducible kinase 2, transcript variant X5
serine/threonine-protein kinase SIK2 isoform X5
serine/threonine-protein kinase SIK2 isoform X6
ALG9 alpha-1,2-mannosyltransferase, transcript variant X3
ALG9 alpha-1,2-mannosyltransferase, transcript variant X7
alpha-1,2-mannosyltransferase ALG9 isoform X3
alpha-1,2-mannosyltransferase ALG9 isoform X7
ALG9 alpha-1,2-mannosyltransferase, transcript variant X4
ALG9 alpha-1,2-mannosyltransferase, transcript variant X1
ALG9 alpha-1,2-mannosyltransferase, transcript variant X2
ALG9 alpha-1,2-mannosyltransferase, transcript variant X6
ALG9 alpha-1,2-mannosyltransferase, transcript variant X5
alpha-1,2-mannosyltransferase ALG9 isoform X4
alpha-1,2-mannosyltransferase ALG9 isoform X1
alpha-1,2-mannosyltransferase ALG9 isoform X2
alpha-1,2-mannosyltransferase ALG9 isoform X6
alpha-1,2-mannosyltransferase ALG9 isoform X5
ferredoxin-fold anticodon binding domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X3
ferredoxin-fold anticodon binding domain containing 1, transcript variant X1
ferredoxin-fold anticodon binding domain containing 1, transcript variant X3
ferredoxin-fold anticodon binding domain containing 1, transcript variant X2
ferredoxin-fold anticodon binding domain containing 1, transcript variant X4
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X1
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X2
chromosome 22 C11orf1 homolog, transcript variant X4
chromosome 22 C11orf1 homolog, transcript variant X5
chromosome 22 C11orf1 homolog, transcript variant X3
UPF0686 protein C11orf1 homolog isoform X2
UPF0686 protein C11orf1 homolog isoform X3
chromosome 22 C11orf1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome 22 C11orf1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
UPF0686 protein C11orf1 homolog isoform X1
chromosome 22 C11orf52 homolog, transcript variant X1
chromosome 22 C11orf52 homolog, transcript variant X2
uncharacterized protein C11orf52 homolog isoform X1
uncharacterized protein C11orf52 homolog isoform X2
DIX domain containing 1, transcript variant X2
DIX domain containing 1, transcript variant X3
DIX domain containing 1, transcript variant X1
DIX domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
DIX domain containing 1, transcript variant X4
DIX domain containing 1, transcript variant X5
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
PIH1 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PIH1 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
PIH1 domain-containing protein 2 isoform X1
PIH1 domain-containing protein 2 isoform X2
NKAP domain containing 1, transcript variant X1
NKAP domain containing 1, transcript variant X2
translocase of inner mitochondrial membrane 8 homolog B
mitochondrial import inner membrane translocase subunit Tim8 B
beta-carotene oxygenase 2, transcript variant X1
beta-carotene oxygenase 2, transcript variant X4
beta,beta-carotene 9',10'-oxygenase isoform X1
beta,beta-carotene 9',10'-oxygenase isoform X4
beta-carotene oxygenase 2, transcript variant X3
beta-carotene oxygenase 2, transcript variant X5
beta,beta-carotene 9',10'-oxygenase isoform X5
beta-carotene oxygenase 2, transcript variant X2
beta,beta-carotene 9',10'-oxygenase isoform X2
beta,beta-carotene 9',10'-oxygenase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122457205, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122457205, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC122457205, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC119846676, transcript variant X1
uncharacterized LOC119846676, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X2
neural cell adhesion molecule 1, transcript variant X7
neural cell adhesion molecule 1, transcript variant X8
neural cell adhesion molecule 1, transcript variant X3
neural cell adhesion molecule 1, transcript variant X9
neural cell adhesion molecule 1, transcript variant X4
neural cell adhesion molecule 1, transcript variant X5
neural cell adhesion molecule 1, transcript variant X6
neural cell adhesion molecule 1 isoform X1
neural cell adhesion molecule 1 isoform X4
neural cell adhesion molecule 1 isoform X2
neural cell adhesion molecule 1 isoform X5
neural cell adhesion molecule 1 isoform X3
neural cell adhesion molecule 1 isoform X6
neural cell adhesion molecule 1 isoform X7
neural cell adhesion molecule 1 isoform X8
neural cell adhesion molecule 1 isoform X9
tetratricopeptide repeat domain 12, transcript variant X4
tetratricopeptide repeat domain 12, transcript variant X1
tetratricopeptide repeat domain 12, transcript variant X2
tetratricopeptide repeat domain 12, transcript variant X5
tetratricopeptide repeat domain 12, transcript variant X3
tetratricopeptide repeat protein 12 isoform X1
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat domain 12, transcript variant X6
tetratricopeptide repeat protein 12 isoform X3
ankyrin repeat and kinase domain containing 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat and protein kinase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane serine protease 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protease serine 5 isoform X1
transmembrane serine protease 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protease serine 5 isoform X2
zw10 kinetochore protein, transcript variant X1
zw10 kinetochore protein, transcript variant X2
centromere/kinetochore protein zw10 homolog isoform X1
centromere/kinetochore protein zw10 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 28, transcript variant X6
ubiquitin specific peptidase 28, transcript variant X4
ubiquitin specific peptidase 28, transcript variant X1
ubiquitin specific peptidase 28, transcript variant X3
ubiquitin specific peptidase 28, transcript variant X7
ubiquitin specific peptidase 28, transcript variant X2
ubiquitin specific peptidase 28, transcript variant X8
ubiquitin specific peptidase 28, transcript variant X5
ubiquitin specific peptidase 28, transcript variant X9
ubiquitin specific peptidase 28, transcript variant X11
ubiquitin specific peptidase 28, transcript variant X10
ubiquitin carboxyl-terminal hydrolase 28 isoform X6
ubiquitin carboxyl-terminal hydrolase 28 isoform X4
ubiquitin carboxyl-terminal hydrolase 28 isoform X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X3
ubiquitin carboxyl-terminal hydrolase 28 isoform X7
ubiquitin carboxyl-terminal hydrolase 28 isoform X5
ubiquitin carboxyl-terminal hydrolase 28 isoform X2
ubiquitin carboxyl-terminal hydrolase 28 isoform X9
ubiquitin carboxyl-terminal hydrolase 28 isoform X8
ubiquitin carboxyl-terminal hydrolase 28 isoform X11
ubiquitin carboxyl-terminal hydrolase 28 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 16, transcript variant X4
zinc finger and BTB domain containing 16, transcript variant X1
zinc finger and BTB domain containing 16, transcript variant X2
zinc finger and BTB domain containing 16, transcript variant X3
zinc finger and BTB domain-containing protein 16
uncharacterized LOC122457206, transcript variant X2
uncharacterized LOC122457206, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
RNA binding motif protein 7, transcript variant X2
RNA binding motif protein 7, transcript variant X1
RNA binding motif protein 7, transcript variant X4
RNA binding motif protein 7, transcript variant X5
RNA binding motif protein 7, transcript variant X3
RNA binding motif protein 7, transcript variant X6
RNA exonuclease 2, transcript variant X1
RNA exonuclease 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 20% coverage of the annotated genomic feature by RNAseq alignments
cell adhesion molecule 1, transcript variant X2
cell adhesion molecule 1, transcript variant X5
cell adhesion molecule 1, transcript variant X1
cell adhesion molecule 1, transcript variant X3
cell adhesion molecule 1, transcript variant X4
uncharacterized LOC122457194, transcript variant X2
uncharacterized LOC122457194, transcript variant X1
uncharacterized LOC122457228, transcript variant X1
uncharacterized LOC122457228, transcript variant X3
uncharacterized LOC122457228, transcript variant X2
uncharacterized LOC122457193, transcript variant X2
uncharacterized LOC122457193, transcript variant X1
stabilizer of axonemal microtubules 1-like, transcript variant X1
stabilizer of axonemal microtubules 1-like, transcript variant X2
stabilizer of axonemal microtubules 1-like isoform X1
stabilizer of axonemal microtubules 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
apolipoprotein C3, transcript variant X1
apolipoprotein C3, transcript variant X2
apolipoprotein A1, transcript variant X2
apolipoprotein A1, transcript variant X1
SIK family kinase 3, transcript variant X6
SIK family kinase 3, transcript variant X10
SIK family kinase 3, transcript variant X7
SIK family kinase 3, transcript variant X14
SIK family kinase 3, transcript variant X13
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X2
SIK family kinase 3, transcript variant X1
SIK family kinase 3, transcript variant X15
SIK family kinase 3, transcript variant X4
SIK family kinase 3, transcript variant X8
SIK family kinase 3, transcript variant X5
SIK family kinase 3, transcript variant X12
SIK family kinase 3, transcript variant X11
SIK family kinase 3, transcript variant X9
serine/threonine-protein kinase SIK3 isoform X11
serine/threonine-protein kinase SIK3 isoform X4
serine/threonine-protein kinase SIK3 isoform X7
serine/threonine-protein kinase SIK3 isoform X8
serine/threonine-protein kinase SIK3 isoform X9
serine/threonine-protein kinase SIK3 isoform X6
serine/threonine-protein kinase SIK3 isoform X5
serine/threonine-protein kinase SIK3 isoform X3
serine/threonine-protein kinase SIK3 isoform X10
serine/threonine-protein kinase SIK3 isoform X2
serine/threonine-protein kinase SIK3 isoform X1
SIK family kinase 3, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
serine/threonine-protein kinase SIK3 isoform X12
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X4
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X2
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X3
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X3
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X2
SID1 transmembrane family member 2, transcript variant X5
SID1 transmembrane family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
SID1 transmembrane family member 2, transcript variant X1
SID1 transmembrane family member 2, transcript variant X3
SID1 transmembrane family member 2, transcript variant X4
SID1 transmembrane family member 2 isoform X1
SID1 transmembrane family member 2 isoform X3
SID1 transmembrane family member 2 isoform X2
SID1 transmembrane family member 2 isoform X4
palmitoyl-protein thioesterase ABHD10, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: palmitoyl-protein thioesterase ABHD10, mitochondrial-like
proprotein convertase subtilisin/kexin type 7, transcript variant X2
proprotein convertase subtilisin/kexin type 7, transcript variant X1
proprotein convertase subtilisin/kexin type 7 isoform X2
proprotein convertase subtilisin/kexin type 7 isoform X1
ring finger protein 214, transcript variant X1
ring finger protein 214, transcript variant X2
ring finger protein 214, transcript variant X3
ring finger protein 214, transcript variant X6
ring finger protein 214, transcript variant X5
ring finger protein 214, transcript variant X4
ring finger protein 214, transcript variant X7
centrosomal protein 164, transcript variant X11
centrosomal protein 164, transcript variant X26
centrosomal protein 164, transcript variant X28
centrosomal protein 164, transcript variant X2
centrosomal protein 164, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein 164, transcript variant X10
centrosomal protein 164, transcript variant X7
centrosomal protein 164, transcript variant X15
centrosomal protein 164, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein 164, transcript variant X1
centrosomal protein 164, transcript variant X9
centrosomal protein 164, transcript variant X4
centrosomal protein 164, transcript variant X5
centrosomal protein 164, transcript variant X6
centrosomal protein 164, transcript variant X12
centrosomal protein 164, transcript variant X13
centrosomal protein 164, transcript variant X19
centrosomal protein 164, transcript variant X20
centrosomal protein 164, transcript variant X21
centrosomal protein 164, transcript variant X25
centrosomal protein 164, transcript variant X22
centrosomal protein 164, transcript variant X23
centrosomal protein 164, transcript variant X24
centrosomal protein 164, transcript variant X27
centrosomal protein 164, transcript variant X29
centrosomal protein 164, transcript variant X16
centrosomal protein 164, transcript variant X3
centrosomal protein of 164 kDa isoform X9
centrosomal protein of 164 kDa isoform X1
centrosomal protein of 164 kDa isoform X5
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X3
centrosomal protein of 164 kDa isoform X6
centrosomal protein of 164 kDa isoform X4
centrosomal protein of 164 kDa isoform X7
centrosomal protein of 164 kDa isoform X8
centrosomal protein of 164 kDa isoform X13
centrosomal protein of 164 kDa isoform X14
centrosomal protein of 164 kDa isoform X15
centrosomal protein of 164 kDa isoform X19
centrosomal protein of 164 kDa isoform X20
centrosomal protein of 164 kDa isoform X22
centrosomal protein of 164 kDa isoform X16
centrosomal protein of 164 kDa isoform X17
centrosomal protein of 164 kDa isoform X18
centrosomal protein of 164 kDa isoform X21
centrosomal protein of 164 kDa isoform X23
centrosomal protein of 164 kDa isoform X10
centrosomal protein 164, transcript variant X17
centrosomal protein 164, transcript variant X18
centrosomal protein of 164 kDa isoform X11
centrosomal protein of 164 kDa isoform X12
DS cell adhesion molecule like 1, transcript variant X2
DS cell adhesion molecule like 1, transcript variant X3
DS cell adhesion molecule like 1, transcript variant X1
Down syndrome cell adhesion molecule-like protein 1 isoform X2
Down syndrome cell adhesion molecule-like protein 1 isoform X3
Down syndrome cell adhesion molecule-like protein 1 isoform X1
DS cell adhesion molecule like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DS cell adhesion molecule like 1, transcript variant X4
Down syndrome cell adhesion molecule-like protein 1 isoform X4
DS cell adhesion molecule like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein 1 isoform X5
DS cell adhesion molecule like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein 1 isoform X6
FXYD domain containing ion transport regulator 2
sodium/potassium-transporting ATPase subunit gamma
FXYD domain containing ion transport regulator 6, transcript variant X5
FXYD domain containing ion transport regulator 6, transcript variant X3
FXYD domain containing ion transport regulator 6, transcript variant X7
FXYD domain containing ion transport regulator 6, transcript variant X4
FXYD domain containing ion transport regulator 6, transcript variant X2
FXYD domain containing ion transport regulator 6, transcript variant X6
FXYD domain containing ion transport regulator 6, transcript variant X1
FXYD domain-containing ion transport regulator 6 isoform X1
FXYD domain-containing ion transport regulator 6 isoform X3
FXYD domain-containing ion transport regulator 6 isoform X2
transmembrane serine protease 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane serine protease 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane serine protease 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane serine protease 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protease serine 4 isoform X1
transmembrane protease serine 4 isoform X2
transmembrane protease serine 4 isoform X3
transmembrane protease serine 4 isoform X4
sodium voltage-gated channel beta subunit 4, transcript variant X1
sodium voltage-gated channel beta subunit 4, transcript variant X2
sodium channel subunit beta-4 isoform X1
sodium channel subunit beta-4 isoform X2
sodium voltage-gated channel beta subunit 2
junction adhesion molecule like, transcript variant X1
junction adhesion molecule like, transcript variant X2
junction adhesion molecule like, transcript variant X3
myelin protein zero like 3, transcript variant X3
myelin protein zero like 3, transcript variant X4
myelin protein zero like 3, transcript variant X1
myelin protein zero like 3, transcript variant X2
myelin protein zero-like protein 3 isoform X4
myelin protein zero-like protein 3 isoform X3
myelin protein zero-like protein 3 isoform X1
myelin protein zero-like protein 3 isoform X2
myelin protein zero like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myelin protein zero like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
myelin protein zero-like protein 2 isoform X1
myelin protein zero-like protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
T-cell surface glycoprotein CD3 epsilon chain
T-cell surface glycoprotein CD3 gamma chain isoform X2
T-cell surface glycoprotein CD3 gamma chain isoform X3
T-cell surface glycoprotein CD3 gamma chain isoform X1
ubiquitination factor E4A, transcript variant X1
ubiquitination factor E4A, transcript variant X4
ubiquitination factor E4A, transcript variant X3
ubiquitination factor E4A, transcript variant X2
ubiquitination factor E4A, transcript variant X5
ubiquitin conjugation factor E4 A isoform X1
ubiquitin conjugation factor E4 A isoform X2
lysine methyltransferase 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lysine methyltransferase 2A, transcript variant X1
lysine methyltransferase 2A, transcript variant X3
lysine methyltransferase 2A, transcript variant X2
histone-lysine N-methyltransferase 2A isoform X1
histone-lysine N-methyltransferase 2A isoform X3
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X4
tetratricopeptide repeat domain 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetratricopeptide repeat domain 36, transcript variant X4
tetratricopeptide repeat domain 36, transcript variant X3
tetratricopeptide repeat domain 36, transcript variant X1
tetratricopeptide repeat protein 36 isoform X1
tetratricopeptide repeat domain 36, transcript variant X5
tetratricopeptide repeat protein 36 isoform X2
transmembrane protein 25, transcript variant X2
transmembrane protein 25, transcript variant X4
transmembrane protein 25, transcript variant X3
transmembrane protein 25, transcript variant X1
intraflagellar transport 46, transcript variant X3
intraflagellar transport 46, transcript variant X4
intraflagellar transport 46, transcript variant X5
intraflagellar transport 46, transcript variant X2
intraflagellar transport 46, transcript variant X1
intraflagellar transport 46, transcript variant X6
intraflagellar transport protein 46 homolog isoform X4
intraflagellar transport protein 46 homolog isoform X3
intraflagellar transport protein 46 homolog isoform X2
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X6
intraflagellar transport protein 46 homolog isoform X5
pleckstrin homology like domain family B member 1, transcript variant X4
pleckstrin homology like domain family B member 1, transcript variant X26
pleckstrin homology like domain family B member 1, transcript variant X28
pleckstrin homology like domain family B member 1, transcript variant X5
pleckstrin homology like domain family B member 1, transcript variant X19
pleckstrin homology like domain family B member 1, transcript variant X1
pleckstrin homology like domain family B member 1, transcript variant X9
pleckstrin homology like domain family B member 1, transcript variant X2
pleckstrin homology like domain family B member 1, transcript variant X7
pleckstrin homology like domain family B member 1, transcript variant X8
pleckstrin homology like domain family B member 1, transcript variant X3
pleckstrin homology like domain family B member 1, transcript variant X6
pleckstrin homology like domain family B member 1, transcript variant X12
pleckstrin homology like domain family B member 1, transcript variant X11
pleckstrin homology like domain family B member 1, transcript variant X13
pleckstrin homology like domain family B member 1, transcript variant X16
pleckstrin homology like domain family B member 1, transcript variant X17
pleckstrin homology like domain family B member 1, transcript variant X18
pleckstrin homology like domain family B member 1, transcript variant X20
pleckstrin homology like domain family B member 1, transcript variant X21
pleckstrin homology like domain family B member 1, transcript variant X24
pleckstrin homology like domain family B member 1, transcript variant X22
pleckstrin homology like domain family B member 1, transcript variant X23
pleckstrin homology like domain family B member 1, transcript variant X25
pleckstrin homology like domain family B member 1, transcript variant X27
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology-like domain family B member 1 isoform X13
pleckstrin homology-like domain family B member 1 isoform X11
pleckstrin homology-like domain family B member 1 isoform X14
pleckstrin homology-like domain family B member 1 isoform X15
pleckstrin homology-like domain family B member 1 isoform X17
pleckstrin homology-like domain family B member 1 isoform X18
pleckstrin homology-like domain family B member 1 isoform X20
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X16
pleckstrin homology-like domain family B member 1 isoform X19
pleckstrin homology-like domain family B member 1 isoform X21
pleckstrin homology-like domain family B member 1 isoform X22
pleckstrin homology-like domain family B member 1 isoform X24
pleckstrin homology like domain family B member 1, transcript variant X10
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X23
pleckstrin homology-like domain family B member 1 isoform X25
pleckstrin homology-like domain family B member 1 isoform X8
pleckstrin homology like domain family B member 1, transcript variant X14
pleckstrin homology like domain family B member 1, transcript variant X15
pleckstrin homology-like domain family B member 1 isoform X12
pleckstrin homology like domain family B member 1, transcript variant X29
pleckstrin homology-like domain family B member 1 isoform X26
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 4 codons; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 4 codons; deleted 2 bases in 2 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
DEAD-box helicase 6, transcript variant X2
DEAD-box helicase 6, transcript variant X1
probable ATP-dependent RNA helicase DDX6
B-cell CLL/lymphoma 9-like protein isoform X2
B-cell CLL/lymphoma 9-like protein isoform X1
B-cell CLL/lymphoma 9-like protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
trafficking protein particle complex subunit 4, transcript variant X2
trafficking protein particle complex subunit 4, transcript variant X1
trafficking protein particle complex subunit 4 isoform X1
trafficking protein particle complex subunit 4 isoform X2
solute carrier family 37 member 4, transcript variant X5
solute carrier family 37 member 4, transcript variant X4
solute carrier family 37 member 4, transcript variant X3
solute carrier family 37 member 4, transcript variant X2
solute carrier family 37 member 4, transcript variant X1
solute carrier family 37 member 4, transcript variant X10
solute carrier family 37 member 4, transcript variant X7
solute carrier family 37 member 4, transcript variant X8
solute carrier family 37 member 4, transcript variant X9
solute carrier family 37 member 4, transcript variant X6
glucose-6-phosphate exchanger SLC37A4 isoform X2
glucose-6-phosphate exchanger SLC37A4 isoform X1
solute carrier family 37 member 4, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glucose-6-phosphate exchanger SLC37A4 isoform X3
hypoxia up-regulated 1, transcript variant X1
hypoxia up-regulated 1, transcript variant X2
hypoxia up-regulated 1, transcript variant X3
hypoxia up-regulated 1, transcript variant X7
hypoxia up-regulated 1, transcript variant X4
hypoxia up-regulated 1, transcript variant X6
hypoxia up-regulated 1, transcript variant X5
hypoxia up-regulated protein 1 isoform X1
hypoxia up-regulated protein 1 isoform X2
VPS11 core subunit of CORVET and HOPS complexes
vacuolar protein sorting-associated protein 11 homolog
hydroxymethylbilane synthase, transcript variant X1
hydroxymethylbilane synthase, transcript variant X3
hydroxymethylbilane synthase, transcript variant X4
hydroxymethylbilane synthase, transcript variant X2
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phospholipid transfer protein C2CD2L isoform X1
phospholipid transfer protein C2CD2L isoform X3
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X4
phospholipid transfer protein C2CD2L isoform X6
phospholipid transfer protein C2CD2L isoform X8
phospholipid transfer protein C2CD2L isoform X7
phospholipid transfer protein C2CD2L isoform X9
phospholipid transfer protein C2CD2L isoform X5
phospholipid transfer protein C2CD2L isoform X10